Related Experiment Video
Updated: Jul 5, 2026

06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Transforming growth factor-beta in cutaneous melanoma
Delphine Javelaud1, Vasileia-Ismini Alexaki, Alain Mauviel
1INSERM U697, Paris, France.
Pigment Cell & Melanoma Research
|April 23, 2008
Summary
Transforming growth factor-beta (TGF-beta) has a dual role in cancer, acting as a tumor suppressor or promoter. This review explores TGF-beta
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor-beta (TGF-beta) exhibits complex roles in carcinogenesis, potentially acting as a tumor suppressor or promoter.
- Increased TGF-beta production correlates with higher tumor grade.
- Melanoma cells resist TGF-beta-induced cell cycle arrest but respond transcriptionally.
Purpose of the Study:
- To review the current understanding of TGF-beta's role in melanoma progression.
- To evaluate the therapeutic potential of targeting TGF-beta signaling in melanoma.
Main Methods:
- Literature review of studies on TGF-beta and melanoma.
- Analysis of TGF-beta's dual functions in cancer.
- Evaluation of melanoma cell response to TGF-beta.
Main Results:
- TGF-beta can suppress tumors via antiproliferative effects.
- TGF-beta can promote tumors by enhancing aggressiveness, angiogenesis, and immune modulation.
- Melanoma cells exhibit unique resistance to TGF-beta's antiproliferative effects.
Conclusions:
- TGF-beta signaling presents a complex target for melanoma therapy.
- Further research is needed to elucidate the precise therapeutic window for targeting TGF-beta in melanoma.
Related Concept Videos
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...

